Goyal T, Singh A, Negi P, Kharkwal B
Department of Orthopaedics, All India Institute of Medical Sciences (AIIMS), Virbhadra Marg, Rishikesh, 248201, India.
Musculoskelet Surg. 2019 Apr;103(1):31-35. doi: 10.1007/s12306-018-0538-8. Epub 2018 May 23.
This is a prospective case-control study comparing short- and medium-term outcomes between sub-acromial and gleno-humeral corticosteroid injections in adhesive capsulitis.
The study population consisted of 105 patients (33 males, 72 females; mean age, 56.1 years). They were divided into three groups: (1) patients receiving 40 mg of methylprednisolone acetate as intra-articular injection (n = 35) followed by physical therapy; (2) patients receiving 40 mg of methylprednisolone acetate as sub-acromial injection (n = 35) followed by physical therapy; (3) patients receiving only physical therapy (heat, passive stretching exercises and wall climbing) and no injections (n = 35). Functional outcome scores (Constant shoulder score and Shoulder Pain and Disability Index), visual analogue scale for pain and range of motion of shoulder joint were noted at 3, 6 and 12 weeks and 6 months.
There was a statistically significant improvement in VAS scores in group 1 and 2 at 3, 6, 12 weeks and 6 months compared to that before the injections. There was no statistically significant improvement in the group 3 at 3 and 6 weeks, but improvement was noticed at 12 weeks and 6 months. There was no statistically significant difference in VAS, CS score, SPADI and ROM between groups 1 and 2 at 3, 6, 12 weeks and 6 months. These scores were significantly better in group 1 and 2 compared to group 3 at 3, 6, 12, weeks and 6 months.
Corticosteroid injections into the sub-acromial space and into the gleno-humeral joint produce similar results in terms of pain relief and improvement in function in patients with adhesive capsulitis.
这是一项前瞻性病例对照研究,比较肩峰下和盂肱关节皮质类固醇注射治疗肩周炎的短期和中期疗效。
研究对象为105例患者(男性33例,女性72例;平均年龄56.1岁)。他们被分为三组:(1)接受40mg醋酸甲泼尼龙关节内注射(n = 35)并随后接受物理治疗的患者;(2)接受40mg醋酸甲泼尼龙肩峰下注射(n = 35)并随后接受物理治疗的患者;(3)仅接受物理治疗(热敷、被动伸展运动和爬墙运动)且未注射药物的患者(n = 35)。在3周、6周、12周和6个月时记录功能结局评分(Constant肩关节评分和肩痛与功能障碍指数)、疼痛视觉模拟量表以及肩关节活动范围。
与注射前相比,第1组和第2组在3周、6周、12周和6个月时的VAS评分有统计学意义的改善。第3组在3周和6周时无统计学意义的改善,但在12周和6个月时有所改善。第1组和第2组在3周、6周、12周和6个月时的VAS、CS评分、SPADI和ROM无统计学意义的差异。在3周、6周及12周和6个月时,第1组和第2组的这些评分显著优于第3组。
肩峰下间隙和盂肱关节注射皮质类固醇在缓解肩周炎患者疼痛和改善功能方面产生相似的结果。